ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,538Medicare Part D Prescriptions Filled, Including Refills

Rank: 46 out of 623

$464K Total Retail Price of All Prescriptions

Rank: 48 out of 623

526 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 526 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 526 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 6,564 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
SIMVASTATIN 424 400 1 2
LISINOPRIL 298 284 2 1
AMLODIPINE BESYLATE 266 220 3 3
LEVOTHYROXINE SODIUM 265 240 4 4
METOPROLOL TARTRATE 186 166 5 9
FUROSEMIDE 185 159 6 5
METOPROLOL SUCCINATE 182 158 7 13
PRAVASTATIN SODIUM 177 152 8 11
HYDROCHLOROTHIAZIDE 164 162 9 8
ATENOLOL 160 146 10 12
METFORMIN HCL 158 141 11 6
ATORVASTATIN CALCIUM 147 144 12 10
POTASSIUM CHLORIDE 126 121 13 24
GLIMEPIRIDE 124 118 14 38
CITALOPRAM HBR 117 106 15 21
CRESTOR 112 108 16 28
TRAMADOL HCL 109 97 17 15
ZOLPIDEM TARTRATE 99 86 18 22
WARFARIN SODIUM 88 84 19 14
TAMSULOSIN HCL 79 78 20 35
LOSARTAN POTASSIUM 72 62 21 16
PANTOPRAZOLE SODIUM 70 69 22 26
IBUPROFEN 69 47 23 68
FENOFIBRATE 69 54 23 71
ACETAMINOPHEN-CODEINE 67 61 S3 25 81
METFORMIN HCL ER 67 57 25 56
SERTRALINE HCL 65 65 27 20
HYDRALAZINE HCL 62 59 28 70
TRICOR 62 53 28 105
CARVEDILOL 61 51 30 32
ALENDRONATE SODIUM 60 47 31 37
OMEPRAZOLE 56 51 32 7
CELEBREX 55 50 33 118
GABAPENTIN 53 42 34 18
NIASPAN 53 43 34 123
RAMIPRIL 53 52 34 79
ALLOPURINOL 53 37 34 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 30, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.